Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
RESEARCH TOOLSreports
WST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$197.01 - $400.88
Previous CloseN/A
Volume102.64K
Average Volume (3M)904.26K
Market Cap
$15.28B
Enterprise Value$21.85B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)31.6
Beta0.77
Next Earnings
Apr 24, 2025EPS Estimate
1.22Last Dividend Ex-Date
Feb 07, 2025Dividend Yield0.38%
Share Statistics
EPS (TTM)6.69
Shares Outstanding72,303,764
10 Day Avg. Volume1,810,211
30 Day Avg. Volume904,256
Standard Deviation0.09
R-Squared0.31
Alpha0.00578
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.31
Price to Cash Flow (P/CF)21.20
P/FCF Ratio38.40
Enterprise Value/Market Cap1.43
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit21.88
Enterprise Value/Ebitda29.37
Forecast
1Y Price Target
$309.00Price Target Upside52.60% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
West Pharmaceutical Services News
PremiumMarket News
VOO ETF News, 2/20/2025
PremiumMarket News
VOO ETF News, 2/14/2025---
Bulls Say, Bears Say
Bulls Say
Competitive PositionWST is considered to have a leading competitive position and value-add opportunity in the packaging space.
Product PortfolioThe margin expansion opportunity is primarily driven by the conversion to the HVP product portfolio, which carries higher margins versus the standard product line.
Sales PerformanceWST reported total sales of $749mn, which was ahead of both BofA and Street estimates.
Bears Say
Earnings GuidanceThe Adj EPS guide in particular was a shock, resulting in WST shares declining by -38% on the day.
HeadwindsUnexpected headwinds lead to yet another reset for WST.
Margin ImpactHVP devices are a drag on margins in the near-to-medium term.
---
Ownership Overview
0.56% Insiders
30.21% Mutual Funds
22.90% Other Institutional Investors
19.75% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
WST FAQ
What was West Pharmaceutical Services, Inc.’s price range in the past 12 months?
West Pharmaceutical Services, Inc. lowest stock price was $197.01 and its highest was $400.88 in the past 12 months.
What is West Pharmaceutical Services, Inc.’s market cap?
West Pharmaceutical Services, Inc.’s market cap is $15.28B.
When is West Pharmaceutical Services, Inc.’s upcoming earnings report date?
West Pharmaceutical Services, Inc.’s upcoming earnings report date is Apr 24, 2025 which is in 63 days.
How were West Pharmaceutical Services, Inc.’s earnings last quarter?
West Pharmaceutical Services, Inc. released its earnings results on Feb 13, 2025. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.719 by $0.101.
Is West Pharmaceutical Services, Inc. overvalued?
According to Wall Street analysts West Pharmaceutical Services, Inc.’s price is currently Undervalued.
Does West Pharmaceutical Services, Inc. pay dividends?
West Pharmaceutical Services, Inc. pays a Quarterly dividend of $0.209 which represents an annual dividend yield of 0.38%. See more information on West Pharmaceutical Services, Inc. dividends here
What is West Pharmaceutical Services, Inc.’s EPS estimate?
West Pharmaceutical Services, Inc.’s EPS estimate is 1.22.
How many shares outstanding does West Pharmaceutical Services, Inc. have?
West Pharmaceutical Services, Inc. has 72,303,764 shares outstanding.
What happened to West Pharmaceutical Services, Inc.’s price movement after its last earnings report?
West Pharmaceutical Services, Inc. reported an EPS of $1.82 in its last earnings report, beating expectations of $1.719. Following the earnings report the stock price went down -38.218%.
Which hedge fund is a major shareholder of West Pharmaceutical Services, Inc.?
Currently, no hedge funds are holding shares in WST
---
West Pharmaceutical Services Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$309.00 (52.60% Upside)
$309.00 (52.60% Upside)
Blogger Sentiment
Bullish
WST Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 18.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $218.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 38.3%
Last 30 Days ▲ 45.9%
Last 30 Days ▲ 45.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.93%
12-Months-Change
Fundamentals
Return on Equity
17.71%
Trailing 12-Months
Asset Growth
-4.86%
Trailing 12-Months
Company Description
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
---
WST Company Deck
---
WST Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted several strategic successes, including growth in the GLP-1 market and strong performance in HPP components. However, challenges in proprietary product revenues, contract manufacturing, and margins were significant issues that tempered the positive aspects. The company is actively addressing these challenges with strategic investments and initiatives.Read More>---
WST Revenue Breakdown
80.69% Proprietary Products
19.31% Contract-Manufactured Products
0.00% Intersegment sales elimination
---
WST Stock 12 Month Forecast
Average Price Target
$309.00
▲(52.60% Upside)
Technical Analysis
Best Analysts Covering WST
1 Year
1 Year Success Rate
7/10 ratings generated profit
1 Year Average Return
+16.41%
reiterated a buy rating 7 days ago
Copying Paul Knight's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +16.41% per trade.
---